{"id":121722,"name":"GSK (FKA GLAXOSMITHKLINE INC.)","slug":"gsk-fka-glaxosmithkline-inc","state":"DC","country":"United States of America","description":"","totalSpending":39880000,"filings":35,"yearlySpending":[{"year":2018,"income":4560000},{"year":2019,"income":4420000},{"year":2020,"income":3770000},{"year":2021,"income":6300000},{"year":2022,"income":5290000},{"year":2023,"income":5130000},{"year":2024,"income":4790000},{"year":2025,"income":5620000}],"issues":["HCR","TRD","CPT","MMM","BUD"],"firms":["GSK (FKA GLAXOSMITHKLINE INC.)"],"lobbyists":["KIMBERLY WILLIAMS","WILLIAM SCHUYLER","JONATHAN CAUSEY","MICHAEL CALVO","PHILIP THEVENET","SHIRA KILCOYNE","ALEC HINOJOSA","JENNIFER DALE","CURTIS RHYNE","ELIZABETH BREWER","AMY EFANTIS","JONATHAN MARTINEZ","MONICA CLOUD","LIAM MACDONALD","HARMEET DHILLON","BRENTON FISK"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","Congressional Budget Office (CBO)","Executive Office of the President (EOP)","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","Office of Administration","Office of Management & Budget (OMB)","Patent & Trademark Office (PTO)","SENATE","U.S. Trade Representative (USTR)","Defense, Dept of (DOD)"],"sampleDescriptions":["H.R. 449: Synthetic Drug Awareness Act: Provisions related to synthetic drug report\nH.R. 749: Lower Drug Costs through Competition Act - Provisions related to generic drug approvals\nH.R. 878: Right to","Trade Agreements and related policy issues\nBiopharmaceutical innovation policy issues\nInternational intellectual property and market access policy issues\nPricing and reimbursement policy issues\nCanada","H.R. 4117: Competitive Deals Resulting in Unleashed Generics and Savings Act of 2017 or the Competitive DRUGS Act of 2017 - Patent Settlements\nH.R. 5340: The Support Technology & Research for Our Nati","H.R. 242: Medicare Prescription Drug Price Negotiation Act of 2017 - Provisions related to Part D and drug pricing negotiation\nH.R. 849: Protecting Seniors Access to Medicare Act - Provisions related ","H.R. 195: Making further continuing appropriation for the fiscal year ending September 30, 2018, and for other purposes.\nH.R. 1625: Consolidated Appropriations Act, 2018\nH.R. 1892: Bipartisan Budget A"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}